Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response
Article in Archives of Dermatological Research (May 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer
Article in Journal of Cancer Research and Clinical Oncology (January 2024)
Big data and single‐cell sequencing in acute myeloid leukemia research
Article in MedComm – Oncology (August 2023)